DrugPatentWatch Database Preview
Profile for Germany Patent: 602004028221
US Patent Family Members and Approved Drugs for Germany Patent: 602004028221
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
➤ Sign Up | Mar 2, 2024 | Sanofi Aventis Us | LANTUS SOLOSTAR | insulin glargine recombinant |
➤ Sign Up | Mar 2, 2024 | Sanofi Aventis Us | APIDRA SOLOSTAR | insulin glulisine recombinant |
➤ Sign Up | Mar 2, 2024 | Sanofi-aventis Us | ADMELOG SOLOSTAR | insulin lispro |
➤ Sign Up | Mar 2, 2024 | Sanofi-aventis Us | SOLIQUA 100/33 | insulin glargine; lixisenatide |
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |